esophageal cancer

Open Access
Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal Cancer
HIROSHI TAMAGAWA, AYAKO TAMAGAWA, TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, AYA KATO, NATSUMI KAMIYA, KAZUKI OTANI, MASAKATSU NUMATA, KEISUKE KAZAMA, JYUNYA MORITA, MIE TANABE, SHIZUNE ONUMA, HARUHIKO CHO, SHO SAWAZAKI, TAKASHI OHSHIMA, NORIO YUKAWA, KENJI MITSUDO, AYA SAITO and YASUSHI RINO

In Vivo September 2023, 37 (5) 2253-2259; DOI: https://doi.org/10.21873/invivo.13327
Open Access
Adverse Events in Patients With Esophageal Cancer Treated With Nivolumab in Combination With Radiotherapy
YASUSHI RINO, TORU AOYAMA, YUKIO MAEZAWA, KAZUKI KANO, MIHWA JU, HIROSHI TAMAGAWA, SHO SAWAZAKI, KEISUKE KAZAMA, HARUKA KANAI, TSUTOMU SATO, AYA SAITO and NORIO YUKAWA

In Vivo July 2023, 37 (4) 1760-1764; DOI: https://doi.org/10.21873/invivo.13264
Open Access
Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal Cancer
YUICHI HIROSHIMA, HITOSHI ISHIKAWA, TAISUKE SUMIYA, MOTOHIRO MURAKAMI, MASATOSHI NAKAMURA, TOSHIKI ISHIDA, KOICHI OGAWA, KATSUJI HISAKURA, MASASHI MIZUMOTO, TATSUYA ODA, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI

In Vivo May 2023, 37 (3) 1253-1259; DOI: https://doi.org/10.21873/invivo.13202
Open Access
Carcinogen 4-Nitroquinoline Oxide (4-NQO) Induces Oncostatin-M (OSM) in Esophageal Cells
AMITAVA MUKHERJEE, MICHAEL W. EPPERLY, RENEE FISHER, DONNA SHIELDS, WEN HOU, ARJUN PENNATHUR, JAMES LUKETICH, HONG WANG and JOEL S. GREENBERGER

In Vivo March 2023, 37 (2) 506-518; DOI: https://doi.org/10.21873/invivo.13108
Open Access
Association Between CYP1A1 Polymorphisms and Esophageal Cancer Susceptibility: A Case-control Study
ZEHRA KAYA and SELVA GURSOY

In Vivo March 2023, 37 (2) 868-878; DOI: https://doi.org/10.21873/invivo.13155
Open Access
Usefulness of Nutrition and Inflammation Assessment Tools in Esophageal Cancer Treatment
TORU AOYAMA, KEISUKE KAZAMA, YUKIO MAEZAWA and KENTARO HARA

In Vivo January 2023, 37 (1) 22-35; DOI: https://doi.org/10.21873/invivo.13051
Open Access
Albumin and Neutrophil-to-Lymphocyte Ratio Score in Neoadjuvant Concurrent Chemoradiotherapy for Esophageal Cancer: Comparison With Prognostic Nutritional Index
WILLIAM HARRISON HSUEH, SHUN-WEN HSUEH, KUN-YUN YEH, YU-SHIN HUNG, MING-MO HO, SHINN-YN LIN, CHEN-KAN TSENG, CHIA-YEN HUNG and WEN-CHI CHOU

In Vivo September 2022, 36 (5) 2400-2408; DOI: https://doi.org/10.21873/invivo.12973
Open Access
Clinical Impact of Platelet-to-albumin Ratio on Esophageal Cancer Patients Who Receive Curative Treatment
TORU AOYAMA, MIWHA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, JUNYA MORITA, ITARU HASHIMOTO, TETSUSHI ISHIGURO, ATSUSHI ONODERA, HARUHIKO CHO, KAZUYA ENDO, SHIZUNE ONUMA, KAZUKI KANO, KENTARO HARA, MOMOKO FUKUDA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO

In Vivo July 2022, 36 (4) 1896-1902; DOI: https://doi.org/10.21873/invivo.12909
Open Access
The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment
TORU AOYAMA, MIWA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, ATSUSHI ONODERA, JUNYA MORITA, ITARU HASHIMOTO, TETSUSHI ISHIGURO, KAZUYA ENDO, HARUHIKO CHO, SHIZUΝE ONUMA, MOMOKO FUKUDA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO

In Vivo July 2022, 36 (4) 1916-1922; DOI: https://doi.org/10.21873/invivo.12912
Open Access
Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment
TORU AOYAMA, MIHWA JU, DAISUKE MACHIDA, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, KAZUKI KANO, KENTARO HARA, KENKI SEGAMI, ITARU HASHIMOTO, SHINSUKE NAGASAWA, MASATO NAKAZONO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO

In Vivo May 2022, 36 (3) 1424-1431; DOI: https://doi.org/10.21873/invivo.12847

Main menu

User menu

Search

esophageal cancer

Pages